Biologics
Waters Corporation and Sartorius Collaborate to Address Cost Reduction and Productivity Challenges in BioPharma Bioprocessing
Building on the success of this initial partnership, on June 4, 2023, Waters and Sartorius announced a new phase of their joint efforts. This time, the col...
July 03, 2023 | News
Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
July 03, 2023 | News
Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology
This marks Cresilon's first FDA clearance for human use, validating its revolutionary hemostatic gel technology and the company's global mission to transfo...
June 30, 2023 | News
BGI Genomics obtains BSI ISO 37301 Compliance Management System Certification
BGI Genomics prioritizes compliance management and strictly follows laws, regulations, and international practices while conducting business globally. BGI ...
June 30, 2023 | News
Thermo Fisher Scientific Introduces Tumor Culture Medium for Faster Cancer Treatment Development
Thermo Fisher Scientific, a global leading company in science services, today announced the launch of the Gibco™ OncoPro™ tumor media kit. *, t...
June 29, 2023 | News
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology
By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...
June 29, 2023 | News
OBiO Technology adds scale-X™ and NevoLine™ Upstream Platform to Accelerate Gene Therapy Manufacturing in Shanghai
The strategic agreement combines the capacity and capabilities of OBiO process development (PD) scientists with enabling platforms and support from...
June 28, 2023 | News
Lymphoma Therapy Approved for Australian Patients with Diffuse Large B-cell Lymphoma
MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-year follow-up data from Phase 2 L-MIND investig...
June 28, 2023 | News
INOVIQ's SubB2M/CA15-3 Breast Cancer Test Shows Excellent Clinical Data
INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) The...
June 28, 2023 | News
Innovent and RemeGen Collaborate on Clinical Trial for Combined Therapy of TYVYT® and Novel ADCs in China
Under the agreement, Innovent will provide clinical drug supplies of TYVYT® (sintilimab injection) during the clinical trial collaboration. RemeGen wil...
June 26, 2023 | News
Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693
Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...
June 26, 2023 | News
Cognigenics' Intranasal CRISPR Delivery Overcomes Blood-Brain Barrier; Promising Therapeutic Breakthrough
Cognigenics CEO John L. Mee announces breakthrough results from an animal study published today in PNAS Nexus. The findings point to the pot...
June 23, 2023 | Analysis
Anthem Biosciences Partners with Veeva to Drive Quality Excellence
Veeva Systems (NYSE: VEEV) announced that fast-growing contract development and manufacturing organization (CDMO) Anthem Biosciences&...
June 22, 2023 | News
Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress
The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...
June 21, 2023 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
